News

The Pharma Letter1m
New indication for Novartis’ twice-yearly Leqvio
The US Food and Drug Administration (FDA) has approved a label update for Swiss pharma giant Novartis’ Leqvio (inclisiran), ...
The Pharma Letter8m
BioNTech misses earnings estimate but beats on revenue
Germany’s BioNTech has reported revenues for the second quarter 2025 of 260.8 million euros ($302 million), more than double ...